WealthTrust Asset Management »

Kalaris Therapeutics shares owned by WealthTrust Asset Management

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by WealthTrust Asset Management from 13F filings

Historical chart of WealthTrust Asset Management investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by WealthTrust Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by WealthTrust Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $72k 12k 5.77

More positions owned by WealthTrust Asset Management

Etf Opportunities Trust Wealthtrust Dbs (WLTG)
Spdr Series Trust State Street Spd (BILS)
C H Robinson Worldwide In Com New (CHRW)
Spdr Series Trust State Street Spd (BIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Us Bancorp Com New (USB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Amazon (AMZN)

View all positions for WealthTrust Asset Management

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Paradigm Biocapital Advisors
Alyeska Investment Group
Siren
Ikarian Capital
Propel Bio Management
Vanguard Group
Vanguard Capital Management
Kalehua Capital Management
Goldman Sachs Group
Woodline Partners
ADAR1 Capital Management
Whi Trust
Boothbay Fund Management

View all funds holding Kalaris Therapeutics